Position in SRRK
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$1,220,741
New position
Shares Held
24,832
first reported quarter
Ownership
0.021%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026D.A. DAVIDSON & CO. holds $25,567,349 across 18 Biotechnology names. SRRK ranks #8 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
558,209 | $4,281,463 | |
| 2 | MRNA |
Moderna, Inc.
|
55,397 | $2,814,167 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
44,063 | $2,489,118 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
98,992 | $2,358,979 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,139 | $2,294,769 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
110,235 | $2,116,512 | |
| 7 | ANIX |
Anixa Biosciences Inc
|
539,272 | $1,391,321 | |
| 8 | SRRK |
Scholar Rock Holding Corp
This page
|
24,832 | $1,220,741 |
All Filings in SRRK
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,220,741 | 24,832 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||